News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
321,022 Results
Type
Article (25531)
Company Profile (36)
Press Release (295455)
Section
Business (81601)
Career Advice (871)
Deals (13554)
Drug Delivery (64)
Drug Development (51373)
Employer Resources (69)
FDA (9358)
Job Trends (7163)
News (157304)
Policy (16104)
Tag
Academia (1865)
Alliances (18974)
Alzheimer's disease (943)
Approvals (9352)
Artificial intelligence (81)
Bankruptcy (140)
Best Places to Work (6288)
Breast cancer (120)
Cancer (896)
Cardiovascular disease (124)
Career advice (732)
CAR-T (64)
Cell therapy (185)
Clinical research (41359)
Collaboration (244)
Compensation (92)
COVID-19 (1331)
Data (1060)
Diabetes (123)
Diagnostics (3186)
Drug pricing (70)
Earnings (34145)
Events (48104)
Executive appointments (204)
FDA (9849)
Funding (237)
Gene therapy (156)
GLP-1 (416)
Government (2716)
Healthcare (10502)
Infectious disease (1389)
Interviews (111)
IPO (6929)
Job creations (1138)
Job search strategy (670)
Layoffs (152)
Legal (2868)
Lung cancer (136)
Lymphoma (72)
Manufacturing (84)
Medical device (6843)
Medtech (6845)
Mergers & acquisitions (6739)
Metabolic disorders (348)
Neuroscience (1154)
NextGen: Class of 2025 (3319)
Non-profit (3044)
Northern California (1008)
Obesity (186)
Opinion (99)
Patents (62)
People (23481)
Phase I (12000)
Phase II (18223)
Phase III (14093)
Pipeline (387)
Podcasts (95)
Policy (67)
Postmarket research (2008)
Preclinical (5500)
Radiopharmaceuticals (129)
Rare diseases (187)
Real estate (1839)
Regulatory (11472)
Research institute (1383)
Resumes & cover letters (119)
Southern California (883)
Startups (1408)
United States (8594)
Vaccines (267)
Weight loss (129)
Date
Today (56)
Last 7 days (210)
Last 30 days (932)
Last 365 days (18741)
2025 (873)
2024 (18919)
2023 (21268)
2022 (25898)
2021 (27881)
2020 (26798)
2019 (24070)
2018 (18140)
2017 (15732)
2016 (15103)
2015 (18134)
2014 (13149)
2013 (10536)
2012 (11330)
2011 (11868)
2010 (11111)
Location
Africa (318)
Arizona (74)
Asia (16104)
Australia (3280)
California (2223)
Canada (750)
China (186)
Colorado (101)
Connecticut (99)
Europe (39898)
Florida (328)
Georgia (77)
Illinois (221)
Indiana (128)
Kansas (67)
Maryland (367)
Massachusetts (1505)
Michigan (75)
Minnesota (144)
New Jersey (696)
New York (674)
North Carolina (440)
Northern California (1008)
Ohio (93)
Pennsylvania (483)
South America (531)
Southern California (883)
Texas (304)
Washington State (252)
321,022 Results for "american heart association aha".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Idorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific Sessions
November 12, 2024
·
5 min read
Press Releases
SonoThera to Present Preclinical Data on Ultrasound-Mediated Gene Delivery Platform to the Heart at the American Heart Association (AHA) Scientific Sessions 2024
November 11, 2024
·
2 min read
Press Releases
Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting
November 18, 2024
·
7 min read
Press Releases
Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations is Among Four Lexicon-Supported Presentations at the American Heart Association’s (AHA) Sessions 2024 in Chicago
November 15, 2024
·
5 min read
Press Releases
Scribe Therapeutics to Present Preclinical Data on CRISPR Genome and Epigenome Editing Technologies at American Heart Association (AHA) Scientific Sessions 2024
October 30, 2024
·
3 min read
Press Releases
Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions
November 18, 2024
·
3 min read
Press Releases
Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024
November 25, 2024
·
5 min read
Press Releases
Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Scientific Sessions
November 11, 2024
·
10 min read
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa) today announced its sponsorship of the American Heart Association’s new Addressing Recurrent Pericarditis initiative, a multi-faceted effort to improve quality of care through identification, dissemination, and implementation of best practices for the diagnosis and management of recurrent pericarditis.
June 17, 2024
·
6 min read
Drug Development
CRISPR Therapeutics Announces Preclinical Data at the American Heart Association (AHA) Scientific Sessions 2023
CRISPR Therapeutics announced preclinical data from the Company’s investigational programs for the treatment of cardiovascular disease, at the American Heart Association Scientific Sessions 2023.
November 6, 2023
·
6 min read
1 of 32,103
Next
